Literature DB >> 20426399

Total synthesis of syringolin A and B.

Michael C Pirrung1, Goutam Biswas, Tannya R Ibarra-Rivera.   

Abstract

Total syntheses of two recently discovered proteasome inhibitors, syringolin A and B, are reported. The key to our approach was creation of the alpha,beta-unsaturated 12-membered lactam via intramolecular Horner-Wadsworth-Emmons reaction. Such reactions have been broadly used to prepared macrolactones, but this work presents a rarer example of its application to macrolactams. The final steps involved attachment of the bis(valinyl)urea side chain using peptide coupling procedures, including a method based on the unprotected valine N-carboxy anhydride. The additional alkene of syringolin A was created through cross-metathesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20426399     DOI: 10.1021/ol100761z

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  12 in total

1.  Enzymatic timing and tailoring of macrolactamization in syringolin biosynthesis.

Authors:  William M Wuest; Daniel Krahn; Markus Kaiser; Christopher T Walsh
Journal:  Org Lett       Date:  2011-08-03       Impact factor: 6.005

2.  Syrbactin Structural Analog TIR-199 Blocks Proteasome Activity and Induces Tumor Cell Death.

Authors:  André S Bachmann; John Opoku-Ansah; Tannya R Ibarra-Rivera; Lisette P Yco; Sudhakar Ambadi; Christopher C Roberts; Chia-En A Chang; Michael C Pirrung
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

3.  Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium tuberculosis Proteasome.

Authors:  Kyle A Totaro; Dominik Barthelme; Peter T Simpson; Xiuju Jiang; Gang Lin; Carl F Nathan; Robert T Sauer; Jason K Sello
Journal:  ACS Infect Dis       Date:  2016-12-05       Impact factor: 5.084

4.  Substrate-guided optimization of the syringolins yields potent proteasome inhibitors with activity against leukemia cell lines.

Authors:  Kyle A Totaro; Dominik Barthelme; Peter T Simpson; Robert T Sauer; Jason K Sello
Journal:  Bioorg Med Chem       Date:  2015-07-26       Impact factor: 3.641

5.  Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivo.

Authors:  Marquicia R Pierce; Reeder M Robinson; Tannya R Ibarra-Rivera; Michael C Pirrung; Nathan G Dolloff; André S Bachmann
Journal:  Leuk Res       Date:  2019-11-12       Impact factor: 3.156

6.  Discovery of a potent and highly β1 specific proteasome inhibitor from a focused library of urea-containing peptide vinyl sulfones and peptide epoxyketones.

Authors:  Wouter A van der Linden; Lianne I Willems; Tamer B Shabaneh; Nan Li; Mark Ruben; Bogdan I Florea; Gijs A van der Marel; Markus Kaiser; Alexei F Kisselev; Herman S Overkleeft
Journal:  Org Biomol Chem       Date:  2011-11-22       Impact factor: 3.876

7.  Total synthesis of fellutamides, lipopeptide proteasome inhibitors. More sustainable peptide bond formation.

Authors:  Michael C Pirrung; Fa Zhang; Sudhakar Ambadi; Y Gangadhara Rao
Journal:  Org Biomol Chem       Date:  2016-08-17       Impact factor: 3.876

8.  Identification of a lysine 4-hydroxylase from the glidobactin biosynthesis and evaluation of its biocatalytic potential.

Authors:  Alexander Amatuni; Hans Renata
Journal:  Org Biomol Chem       Date:  2019-02-13       Impact factor: 3.876

9.  Concise Chemoenzymatic Total Synthesis and Identification of Cellular Targets of Cepafungin I.

Authors:  Alexander Amatuni; Anton Shuster; Alexander Adibekian; Hans Renata
Journal:  Cell Chem Biol       Date:  2020-08-06       Impact factor: 8.116

10.  Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition.

Authors:  S Kitahata; F Yakushiji; S Ichikawa
Journal:  Chem Sci       Date:  2017-08-11       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.